India to Afghanistan: Carfilzomib Export Trade Route

The India to Afghanistan Carfilzomib corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $16.0K USD. The route is dominated by SARTAJ PHARMA PRIVATE LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's carfilzomib manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $4.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with carfilzomib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 34.9%, placing it at rank #1 among India's top carfilzomib export destinations globally.

On the import side, key buyers of Indian carfilzomib in Afghanistan include SARTAJ ENTERPRIESES LIMITED, SHAHID KHAN, TO.,. SARTAJ ENTERPRIESES LIMITED is the single largest importer with 1 shipments valued at $11.7K USD.

India's carfilzomib exports to Afghanistan are driven primarily by a handful of large-scale manufacturers. SARTAJ PHARMA PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Afghanistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SARTAJ PHARMA PRIVATE LIMITED, KERK, MBA PHARMACEUTICALS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $4.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as carfilnat 60mg injection.b.no: jd40823010/mfg-11/23 exp-4/25[carfilzomib 60mg] and pharma products-(carfilzomib for injection 60mg)-b.no-l23cz11b5,mfg-nov-23,exp-oct-25, suggesting that buyers in Afghanistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SARTAJ ENTERPRIESES LIMITED is the largest importer with 1 shipments worth $11.7K USD — representing 74% of all carfilzomib imports from India on this route.